Recommendations for Day 1

Recommendations for the ESCRS meeting from Fedra Pavlou | Editor, OT Europe and Dr Jorge Alio.

Related Videos

View All

Related Content

NIH scientists create eye tissue using 3D bioprinting

January 28th 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

Vial partners with RecensMedical in phase 3 clinical trial

January 27th 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Ocuphire Pharma’s ZETA-1 phase 2 trial of diabetic retinopathy candidate offers mixed results

January 26th 2023

IDEAYA announces darovasertib Phase 2 initiation in neoadjuvant and adjuvant uveal melanoma

January 26th 2023

NIH scientists create eye tissue using 3D bioprinting

January 28th 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

Vial partners with RecensMedical in phase 3 clinical trial

January 27th 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Ocuphire Pharma’s ZETA-1 phase 2 trial of diabetic retinopathy candidate offers mixed results

January 26th 2023

IDEAYA announces darovasertib Phase 2 initiation in neoadjuvant and adjuvant uveal melanoma

January 26th 2023

NIH scientists create eye tissue using 3D bioprinting

January 28th 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

Vial partners with RecensMedical in phase 3 clinical trial

January 27th 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Ocuphire Pharma’s ZETA-1 phase 2 trial of diabetic retinopathy candidate offers mixed results

January 26th 2023

IDEAYA announces darovasertib Phase 2 initiation in neoadjuvant and adjuvant uveal melanoma

January 26th 2023

Related Content

---

NIH scientists create eye tissue using 3D bioprinting

Articles

---

Commercial real estate and your practice, part two with Colin Carr

Podcasts

---

Vial partners with RecensMedical in phase 3 clinical trial

Articles

---

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

Podcasts

---

Ocuphire Pharma’s ZETA-1 phase 2 trial of diabetic retinopathy candidate offers mixed results

Articles

---

IDEAYA announces darovasertib Phase 2 initiation in neoadjuvant and adjuvant uveal melanoma

Articles